The aim of this session is to provide an update on novel biomarkers and classification phenotypes for the early recognition of sepsis.

Agenda:

• Biomarkers of Relevance in Low-Resource Settings
• A Patient is Admitted at the Emergency: What to Do?
• Clinical Phenotypes: What Do They Suggest?
• Biomarkers as Endpoints for Treatment Efficacy
• Reducing Antibiotics With a Single Host Biomarker in Neonates Suspected of LOS: The EMERAUDE Study